Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from

Fabio Mangiacapra1, Marco Giuseppe Del Buono2, Antonio Abbate3

  • 1Unit of Cardiovascular Science, Campus Bio-Medico University, Rome, Italy.

Insights

Endothelial dysfunction (EnD) is a key factor in coronary artery disease (CAD) and can cause persistent angina after percutaneous coronary intervention (PCI). Assessing EnD may identify high-risk patients needing intensive treatment.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Endothelial dysfunction (EnD) is a primary driver of coronary artery disease (CAD) pathogenesis and atherosclerotic plaque development.
  • Percutaneous coronary intervention (PCI) is a common treatment for symptomatic CAD, yet a significant number of patients experience persistent angina post-procedure.
  • EnD contributes to persistent angina after PCI through persistent structural and functional coronary artery abnormalities.

Purpose of the Study:

  • To review the role of endothelial dysfunction (EnD) in causing angina following percutaneous coronary intervention (PCI).
  • To discuss the pathophysiological mechanisms, diagnostic methods, and therapeutic strategies related to EnD and post-PCI angina.

Main Methods:

  • Literature review focusing on endothelial function, coronary artery disease, percutaneous coronary intervention, and angina.
  • Analysis of pathophysiological mechanisms linking EnD to post-PCI symptoms.
  • Evaluation of current diagnostic approaches and emerging therapeutic perspectives for EnD.

Main Results:

  • Endothelial dysfunction is intrinsically linked to the development and progression of CAD.
  • Persistent EnD post-PCI contributes significantly to angina symptoms, even after successful revascularization.
  • Assessment of endothelial function may stratify patients for risk of cardiovascular events and recurrent angina.

Conclusions:

  • Endothelial dysfunction is a critical determinant of angina following PCI.
  • Identifying and managing EnD is crucial for improving outcomes in patients undergoing PCI.
  • Further research into diagnostic and therapeutic interventions targeting EnD is warranted to reduce persistent angina and cardiovascular risk.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
192
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
246
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
186
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
162
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
403
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
187